Search Results

You searched for : BARDA  

CDC says 3 feet of distance enough for schoolers

New school safety guidelines from CDC...
Mar 20

FUJIFILM Diosynth Biotechnologies begins production of two COVID-19 vaccines

FUJIFILM Diosynth Biotechnologies announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government...
Jan 19

Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its VITROS® SARS-CoV-2 Antigen Test, designed to detect active infection, ...
Jan 13

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses

The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ...
Jan 13

RedHill's phase 2/3 COVID-19 study of opaganib passes second DSMB with unanimous recommendation to continue

Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication ...
Dec 22

The RedHill Phase II / III candidate opaganib reduces ARDS-related blood clotting in the preclinical model in COVID-19 patients

The results also show that opaganib inhibits SARS-CoV-2 virus replication and proinflammatory markers in relevant preclinical models ...
Dec 17

Moderna announces amendment to supply agreement of COVID vaccine with the ministry of health of Israel

This agreement will support the ongoing efforts by the Ministry to secure early access to a COVID-19 vaccine for the people of Israel...
Dec 05

RedHill announces DSMB unanimous recommendation to continue COVID-19 opaganib phase 2/3 study

The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia...
Nov 23

Regeneron's REGEN-COV2 is first antibody cocktail for COVID-19 to receive US FDA emergency use authorization

The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ...
Nov 23

European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older

The European Commission has granted marketing authorization for Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 ...
Nov 20

Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19

This agreement comes as the UK continues its efforts to secure access to safe and effective COVID-19 vaccines...
Nov 19

Regeneron’s Antibody cocktail REGN-EB3 (Inmazeb) is first FDA-Approved treatment for Ebola

First FDA approved antibody treatment for Ebola...
Oct 19

Trump Administration Expands Collaboration with AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19

The goal of AstraZeneca's partnership with the U.S. Government is to develop a monoclonal antibody cocktail that can help prevent infection....
Oct 10

COVID-19 AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials

The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus....
Oct 09

COVID-19 AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials

The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus....
Oct 09

NIH RADx initiative advances six new COVID-19 testing technologies

...
Oct 07

Regeneron Pharma announced, result of Phase 1/2/3 trial of antibody cocktail REGN-COV2

Regenerons REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients...
Oct 02

Veeva and Bioforum partner with RedHill Biopharma to maximize Opaganib Phase 2/3 COVID-19 Clinical Data

Veeva Vault CDMS and Bioforum selected to optimize clinical data management for RedHill’s global Phase 2/3 clinical trial ...
Sep 25

CHMP recommends approval of Supemtek for the prevention of influenza in adults aged 18 and above

CHMP has adopted a positive opinion for Supemtek for active immunization for the prevention of influenza in adults...
Sep 23

Johnson & Johnson initiates phase 3 clinical trial for COVID-19 vaccine Candidate

The Company is committed to bringing an affordable vaccine to the public on a not-for-profit basis for emergency pandemic use...
Sep 23

Vaxart announces FDA clearance of IND application for oral COVID-19 Vaccine

Oral Covid vaccine gains ground...
Sep 18

Vaccine nationalism puts lives at risk says European Union chief

In her first annual State of the European Union address, Ursula von der Leyen said the coronavirus pandemic ...
Sep 17

AstraZeneca to start Phase 3 trials of COVID vaccine in United States

AstraZeneca closer to COVID vaccine as 3rd phase trial starts...
Sep 01

FUJIFILM to support COVID-19 vaccine candidate manufacturing

FUJIFILM Diosynth Biotechnologies will support COVID-19 vaccine candidate manufacturing, as part of Operation Warp Speed, a U.S. government program...
Jul 31

BD partners with U.S. Government for Mass Vaccination campaign

...
Jul 17

25 Matching result(s) found!

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
From Heart Defect to High Seas: Robot-Assisted Surgery at Fortis Escorts Okhla Helps 26-Year-Old Merchant Navy Officer Pursue His CareerSeptember 17, 2026
Apollo Hospitals, Bengaluru performs India’s first EXIME temporary prostatic stent procedure; five patients treatedSeptember 17, 2026
Rela Hospital and Smile Train Launch India’s Largest and Most Comprehensive Cleft Care Reference CentreSeptember 17, 2026
Max Healthcare Foundation Expands Max Medical Scholarship to Fund Education of 250 Meritorious MBBS Students in its 4th YearSeptember 17, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026